Colorectal Cancer Genetics: An Overview of the Actionable Building Blocks
- 29 September 2020
- book chapter
- other
- Published by Springer Science and Business Media LLC
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- PTEN expression is consistent in colorectal cancer primaries and metastases and associates with patient survivalCancer Medicine, 2013
- Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumabCancer Medicine, 2013
- Promising biomarkers for predicting the outcomes of patients withKRASwild-type metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: A systematic review with meta-analysisInternational Journal of Cancer, 2013
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort studyThe Lancet Oncology, 2011
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysisThe Lancet Oncology, 2010
- Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximabEuropean Journal of Cancer, 2010
- Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancerInternational Journal of Cancer, 2010
- Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancerThe Lancet Oncology, 2008
- Mutations of the PIK3CA gene in hereditary colorectal cancersInternational Journal of Cancer, 2007